| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 Feb 2026 | 29 Jan 2026 |
| Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Monday February 092026 to consider and approve the un-audited standalone and consolidated financials results. Outcome of Board Meeting held on February 09, 2026 pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement dated on: 09.02.2026) | ||
| Board Meeting | 19 Dec 2025 | 19 Dec 2025 |
| Outcome of Board Meeting held on December 19,2025 to consider and approve scheme of amalgamation. | ||
| Board Meeting | 15 Nov 2025 | 15 Nov 2025 |
| Outcome of the Board Meeting held on November 15,2025 for withdrawal of the application under regulation 37 of SEBI (LODR) Regulations, 2015 for obtaining NOC from Stock Exchanges in respect of proposed Scheme of Amalgamation. | ||
| Board Meeting | 5 Nov 2025 | 29 Oct 2025 |
| Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve the un-audited standalone and consolidated Financial Results for the quarter and half year ended September 30,2025 Outcome of the Board Meeting held on November 05,2025 for declaration of Unaudited standalone and cosolidated financial results of the company for the quarter and half year ended September 30,2025 Un-audited Financial Results for the quarter and half year ended September 30,2025 (As Per BSE Announcement Dated on:05.11.2025) | ||
| Board Meeting | 1 Aug 2025 | 22 Jul 2025 |
| Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve To Consider and approve the Un-audited Standalone and Financial Results for the quarter ended on June 302025 Outcome of the the Board Meeting held on August 01,2025 to consider and approve Unaudited standalone and consolidated financial results of the company for the quarter ended June 30,2025. (As Per BSE Announcement Dated on: 01.08.2025) | ||
| Board Meeting | 14 Jun 2025 | 14 Jun 2025 |
| Outcome of the Board Meeting held on June 14,2025 Pursuant to Regulation 30 of SEBI (LODR) Regulations,2015 | ||
| Board Meeting | 3 May 2025 | 22 Apr 2025 |
| Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2025 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Saturday May 032025 Outcome of the Board Meeting held on Saturday, May,03,2025 Pursuant to Regulation 30 read with Regulation 33 of SEBI (LODR) Regulations,2015. (As Per BSE Announcement Dated on:03.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
